L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
JVc3k0GryDNVtTL9
